Member Info for BasilAlderman

My goodness £10 billion in patents to replace. Now where could GSK get some of that future revenue? Perhaps by ringing Tim Mitchell on 01223 497700 . Anyway, great post about GSK. They are certainly a probability for licencing or taking over Sareum. They have deep pockets.

Exactly. No one that has held for this long is going to sell at these prices when we have all done our background research on the deals that have been struck in our sector for takeovers and licencing. We are talking big money for Sareum. As many posters have pointed out a x 1 rise from today would see us at 14p approx with a further x 1 rise equating to 28p approx. The right news will take us to 14p and then 28p+. When that happens 55p to 60p will be just another x 1.

LeMajor I agree with your 18-25p over the next few weeks. Your point is not dissimilar to many other credible voices on here who have been uncanny with their price predictions for SAR. Yesterday was a pivotal day to confirm and reassure the market that indeed Sareum does have the winning formula. The next few RNS' will propel the Sareum share price substantially higher. The foundations are in place.

Yes Baton, according to Stoney at 11.27am he left us hanging with this intriguing message "IMHO tomorrow could be a good news day......". it's worth seeing his post as it's an interesting theory. He's been pretty consistent and accurate with his predictions.

There are some good chunky buys going through ...
6.999 1,114,345 Buy* 6.40 6.50 77.99k
7.00 500,000 Buy* 6.40 6.60 35.00k
6.97 1,000,000 Buy* 6.40 6.50 69.70k
6.85 722,765 Buy* 6.50 6.60 49.51k
6.825 780,000 Buy* 6.50 6.60 53.24k

Those 50,000 transactions at 29p on Tuesday 29th June were quite fascinating. I've never seen anything like that and then today we get the Covid RNS. Amazing few days here.

29-Jun-21 14:52:48 29.00 -50,000 Buy* 5.70 5.90 -14.50k O
29-Jun-21 14:54:18 29.00 -50,000 Buy* 5.70 5.90 -14.50k O
29-Jun-21 14:52:48 29.00 50,000 Buy* 5.70 5.90 14.50k O
29-Jun-21 14:54:18 29.00 50,000 Buy* 5.70 5.90 14.50k O

The fact that SDC-1801 is superior to dexamethasone is brilliant news. The NHS is on record as saying back in March that 22,000 Covid patients had been saved in the UK and over 1 million worldwide thanks to dexamethasone. What price do you put on a drug that is better than the current life saver? Sareum is now in the shop window. Big news and big deals are on the way.

Hey Elcap, I remember your 16th July 2020 post re the takeover panel email from Stephen Parker. How very interesting things have turned out in the last few days. Something is going on behind the scenes.

I'm expecting regular news announcements from Sareum with much bigger news over the coming weeks. e.g. Agile, licencing or even a takeover. This is hold for gold as they say. Boil B predicted 20p this week. He could be right. His predictions have been pretty accurate and I still remember PYC going up from 4p to 30p in 4 days. We are on our way.

Yes, a multi billion takeover must be on the cards now. Amazing RNS for all Sareum investors and for the pharma sector / patients in the future. That 50,000 trade at 29p is certainly arousing some curiosity now! A 29p takeover? Not for me. £1+ is what I'm interested in. This is simply massive news today. We already knew that Sareum’s science in combination with Dexamethasone, AstraZeneca's WEE1 adavosertib, Merck’s Keytruda and Eli Lillys Gemcitabine all worked. Sareum's value has just sky rocketed. Congratulations to John and Tim. Now it's time for Dr Owen and Dr Parker to extract the highest price and we know with Kymab's 1.4 billion sale to Sanofi in January that Dr Owne knows how to create value.

The mystery 29p a share transaction flagged up today by WIP, Dr Zed, AndyMK, Potnak and many others that might have happened yesterday could turn out to be rather interesting. Hypothetically if a 29p trade went through the Takeover Code is that further down the line the person or group making the bid (if they are the same entity) must make a cash offer to all other shareholders at the highest price paid in the 12 months before an offer was announced. i.e. 29p. It's an interesting theory and would support some of the posts on here over the last few months about a possible T/O. One to watch. There are amendments to the Code which come into effect on Monday 5 July. See https://www.thetakeoverpanel.org.uk/the-code/download-code

Whilst we wait for news that is without a doubt the best post of the day! Well done Simon and a brilliant reminder of the massive potential of Sareum.

What is also indisputable are the facts that:
Sareum in combination with Dexamethasone works.
Sareum in combination with AstraZeneca's WEE1 works.
Sareum in combination with Merck’s Keytruda works.
Sareum in combination with Eli Lilly's Gemcitabine works. i.e. we are not going un-noticed by big pharmas which in our sector equates to serious money.

Plus we are about to find out how our Covid research is panning out. When you factor in the recent statement from Sareum that "initial results from this research are encouraging and demonstrate that SDC-1801 reduces the levels of cytokines associated with Acute Respiratory Distress Syndrome in human lung cells infected with SARS-CoV-2" and, as Potnak has reminded us many times, that no speeding tickets have been issued you can only conclude that the next piece of news is going to be very significant and momentous.

WIP and Brighty, well said for succinctly reinforcing how the SAR share price could x 10 over a relatively short period of time from our current 6p to a likely 60p. Many small plcs on AIM have done so over the years and in the last 12 months many in the pharma space in particular have achieved exactly this. Once we get to Thoth's 28p per share the rises as you say are pretty modest to take us to £1 a share. I think it's going to happen.

Many of the recent and arguably most important updates from Sareum have NOT been issued at 7am, including the Covid 19 Research grant announcement and Hnwi investment. In summary, with SAR an RNS could come at any time of the day. See below:

11AM
Notification of Grant Award for Covid-19 Research
Tue, 27th Oct 2020 11:00

2.07PM
Research Update
Thu, 25th Mar 2021 14:07

11.19AM
Subscription to raise £1,470,000
Tue, 15th Jun 2021 11:19

8AM
Sareum to Present at BioTrinity 2021 Conference
Mon, 21st Jun 2021 08:00

Jon, spot on. Agile would equate to at least 20p a share immediately it was confirmed. We are 6p+. SNG went from 6p to over 200p in 6 months. The same could occur here.

The Sareum science in combination with Dexamethasone works.
The Sareum science in combination with AstraZeneca's WEE1 inhibitor adavosertib works.
The Sareum science in combination with Merck’s Keytruda works.
The Sareum science in combination with Eli Lillys Gemcitabine works.
In a nutshell our science is being proven to work time and time again and this surely equates to big news and big bucks soon.

Whoever it was that Tweeted this lifted my post from 9.39am today, above, word for word!

Yes, 7p a share will look cheap soon when more and more investors cotton on to the fact that the Sareum science is the real deal and works with Dexamethasone, Adavosertib, Keytruda and Gemcitabine. Big money in the pharma sector is paid for this kind of success rate.

What excites me the most is whether it is Dexamethasone or not what we do know is that the Sareum science in combination with Dexamethasone works. The Sareum science in combination with AstraZeneca's WEE1 inhibitor adavosertib works. The Sareum science in combination with Merck’s Keytruda works. The Sareum science in combination with Eli Lillys Gemcitabine works. In a nutshell our science is being proven to work time and time again and this surely equates to big news and big bucks soon.

7p incoming and an 8p close today would set things up brilliantly for the projected news flow we are expecting. Don't forget Boil B's 20p by the end of June prediction - he's been pretty accurate so far with his predictions. FOMO Friday etc.

It is certainly one to watch with Sareum re our UKRI research as Dexamethasone – already prescribed for many conditions for its anti-inflammatory effects – was shown to reduce deaths by a third for Covid-19 patients on ventilators. It was revealed in March that one million lives had been saved globally by dexamethasone treatment re Covid. Now if you add the 2019 ground breaking successful research undertaken by Sareum with dexamethasone in to the UKRI mix this is pretty exciting.